Gang Yang1, Xiao-Ting Wu, Yong Zhou, Ying-Li Wang. 1. Department of General Surgery, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu 610041, Sichuan Province, China. yanggang2000@hotmail.com
Abstract
AIM: To evaluate the effects of dietary fiber (DF) as a part of enteral nutrition (EN) formula on diarrhea, infection, and length of hospital stay. METHODS: Following electronic databases were searched for randomized controlled trials about DF: Chinese Biomedicine Database (CBM), MEDLINE, EMBASE and Cochrane Controlled Trials Register. RevMan 4.1 was used for statistical analysis. RESULTS: Seven randomized controlled trials with 400 patients were included. The supplement of DF in EN was compared with standard enteral formula in five trials. Combined analysis did not show a significant reduction in occurrence of diarrhea, but there were valuable results for non-critically ill patients. Combined analysis of two trials observing the infection also did not show any valid evidence that DF could decrease the infection rate, though the length of hospital stay was reduced significantly. CONCLUSION: Based on the current eligible randomized controlled trials, there is no evidence that the value of DF in the diarrhea can be proved. Though length of hospital stay was shortened by the use of DF, there is no available evidence in preventing infection by DF. Further studies are needed for evaluating the value of DF in EN.
AIM: To evaluate the effects of dietary fiber (DF) as a part of enteral nutrition (EN) formula on diarrhea, infection, and length of hospital stay. METHODS: Following electronic databases were searched for randomized controlled trials about DF: Chinese Biomedicine Database (CBM), MEDLINE, EMBASE and Cochrane Controlled Trials Register. RevMan 4.1 was used for statistical analysis. RESULTS: Seven randomized controlled trials with 400 patients were included. The supplement of DF in EN was compared with standard enteral formula in five trials. Combined analysis did not show a significant reduction in occurrence of diarrhea, but there were valuable results for non-critically ill patients. Combined analysis of two trials observing the infection also did not show any valid evidence that DF could decrease the infection rate, though the length of hospital stay was reduced significantly. CONCLUSION: Based on the current eligible randomized controlled trials, there is no evidence that the value of DF in the diarrhea can be proved. Though length of hospital stay was shortened by the use of DF, there is no available evidence in preventing infection by DF. Further studies are needed for evaluating the value of DF in EN.
Authors: D J Jenkins; C W Kendall; V Vuksan; L S Augustin; Y M Li; B Lee; C C Mehling; T Parker; D Faulkner; H Seyler; E Vidgen; V Fulgoni Journal: J Am Coll Nutr Date: 1999-08 Impact factor: 3.169
Authors: John M Hebden; Elaine Blackshaw; Massimo D'Amato; Alan C Perkins; Robin C Spiller Journal: Am J Gastroenterol Date: 2002-09 Impact factor: 10.864
Authors: G C Parisi; M Zilli; M P Miani; M Carrara; E Bottona; G Verdianelli; G Battaglia; S Desideri; A Faedo; C Marzolino; A Tonon; M Ermani; G Leandro Journal: Dig Dis Sci Date: 2002-08 Impact factor: 3.199
Authors: Hannah Wozniak; Tal Sarah Beckmann; Lorin Fröhlich; Tania Soccorsi; Christophe Le Terrier; Aude de Watteville; Jacques Schrenzel; Claudia-Paula Heidegger Journal: Crit Care Date: 2022-08-18 Impact factor: 19.334